AUPH FY 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$318,000-31.3% YoY

Gross Profit

$318,000100.0% margin

Operating Income

-$91M-28598.4% margin

Net Income

-$88M-27794.0% margin

EPS (Diluted)

$-1.33

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$64M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$324M

Total Liabilities

$26M

Stockholders' Equity

$299M

Cash & Equivalents

$306M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$318,000	$463,000	-31.3%
Gross Profit	$318,000	-$41M	+100.8%
Operating Income	-$91M	-$56M	-61.9%
Net Income	-$88M	-$64M	-37.8%